{"title":"Evaluation of polyherbal synergy against diabetes: <i>in-vitro</i> analysis.","authors":"Sridevi N, Thirumal M","doi":"10.1080/20565623.2025.2468128","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the anti-diabetic properties of a polyherbal formulation consisting of <i>Curcuma longa</i>, <i>Emblica officinalis</i>, and <i>Trigonella foenum-graecum</i> through <i>in-vitro</i> assays, and investigate its synergistic effects on glucose metabolism, lipid metabolism, and insulin function.</p><p><strong>Materials and methods: </strong>The polyherbal extract was prepared using methanol, water, and methanol-water as solvents. <i>In-vitro</i> antioxidant (DPPH, Phosphomolybdenum) and anti-diabetic (α-amylase, α-glucosidase inhibition, yeast glucose uptake, and inhibitory glucose diffusion) assays were conducted. L6 rat skeletal muscle cells were used for MTT assay and glucose uptake.</p><p><strong>Results: </strong>The methanol extract showed the highest antioxidant and anti-diabetic activities compared to aqueous and hydroalcoholic extracts. The IC<sub>50</sub> values in DPPH and α-amylase inhibition assays were close to standard drugs, while the MTT assay demonstrated moderate cytotoxicity, confirming the extract's safety. Glucose uptake increased significantly, particularly in L6 cells treated with the methanolic extract.</p><p><strong>Conclusion: </strong>The polyherbal formulation exhibited potent anti-diabetic properties, particularly the methanolic extract, showing significant glucose regulation and insulin function improvement. This formulation holds promise as a natural treatment for diabetes.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2468128"},"PeriodicalIF":2.4000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11849915/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20565623.2025.2468128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To evaluate the anti-diabetic properties of a polyherbal formulation consisting of Curcuma longa, Emblica officinalis, and Trigonella foenum-graecum through in-vitro assays, and investigate its synergistic effects on glucose metabolism, lipid metabolism, and insulin function.
Materials and methods: The polyherbal extract was prepared using methanol, water, and methanol-water as solvents. In-vitro antioxidant (DPPH, Phosphomolybdenum) and anti-diabetic (α-amylase, α-glucosidase inhibition, yeast glucose uptake, and inhibitory glucose diffusion) assays were conducted. L6 rat skeletal muscle cells were used for MTT assay and glucose uptake.
Results: The methanol extract showed the highest antioxidant and anti-diabetic activities compared to aqueous and hydroalcoholic extracts. The IC50 values in DPPH and α-amylase inhibition assays were close to standard drugs, while the MTT assay demonstrated moderate cytotoxicity, confirming the extract's safety. Glucose uptake increased significantly, particularly in L6 cells treated with the methanolic extract.
Conclusion: The polyherbal formulation exhibited potent anti-diabetic properties, particularly the methanolic extract, showing significant glucose regulation and insulin function improvement. This formulation holds promise as a natural treatment for diabetes.
期刊介绍:
Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries